These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12659982)

  • 1. New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada.
    Bentkover JD; Stewart EJ; Ignaszewski A; Lepage S; Liu P; Cooper J
    Int J Cardiol; 2003 Mar; 88(1):33-41. PubMed ID: 12659982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.
    Crespo C; Linhart M; Acosta J; Soto-Iglesias D; Martínez M; Jáuregui B; Mira Á; Restovic G; Sagarra J; Auricchio A; Fahn B; Boltyenkov A; Lasalvia L; Sampietro-Colom L; Berruezo A
    Eur J Prev Cardiol; 2020 Apr; 27(6):622-632. PubMed ID: 31487998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of a randomized trial of biventricular pacing in Canada.
    Bentkover JD; Dorian P; Thibault B; Gardner M
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of supervised exercise therapy in heart failure patients.
    Kühr EM; Ribeiro RA; Rohde LE; Polanczyk CA
    Value Health; 2011; 14(5 Suppl 1):S100-7. PubMed ID: 21839879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of medical assistance in dying in Canada.
    Trachtenberg AJ; Manns B
    CMAJ; 2017 Jan; 189(3):E101-E105. PubMed ID: 28246154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waste in the US Health Care System: Estimated Costs and Potential for Savings.
    Shrank WH; Rogstad TL; Parekh N
    JAMA; 2019 Oct; 322(15):1501-1509. PubMed ID: 31589283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: cardiac resynchronization in patients with symptomatic heart failure.
    McAlister FA; Ezekowitz JA; Wiebe N; Rowe B; Spooner C; Crumley E; Hartling L; Klassen T; Abraham W
    Ann Intern Med; 2004 Sep; 141(5):381-90. PubMed ID: 15353430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimates of the direct and indirect cost savings associated with heart disease that could be avoided through dietary change in the United States.
    Cawley J; Meyerhoefer C; Gillingham LG; Kris-Etherton P; Jones PJ
    J Med Econ; 2017 Feb; 20(2):182-192. PubMed ID: 27724055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Value and Cost-Effectiveness of Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2017 Mar; 5(3):204-212. PubMed ID: 28254126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness for introducing nurse practitioners in six long-term care facilities in Québec, Canada: A cost-savings analysis.
    Tchouaket É; Kilpatrick K; Jabbour M
    Nurs Outlook; 2020; 68(5):611-625. PubMed ID: 32713732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and savings associated with community water fluoridation programs in Colorado.
    O'Connell JM; Brunson D; Anselmo T; Sullivan PW
    Prev Chronic Dis; 2005 Nov; 2 Spec no(Spec No):A06. PubMed ID: 16263039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy (CRT) in heart failure--a model to assess the economic value of this new medical technology.
    Banz K;
    Value Health; 2005; 8(2):128-39. PubMed ID: 15804321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model.
    Bilandzic A; Rosella L
    Health Promot Chronic Dis Prev Can; 2017 Feb; 37(2):49-53. PubMed ID: 28273040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure.
    Ward RE; Gheorghiade M; Young JB; Uretsky B
    J Am Coll Cardiol; 1995 Jul; 26(1):93-101. PubMed ID: 7797781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.
    Borisenko O; Müller-Ehmsen J; Lindenfeld J; Rafflenbeul E; Hamm C
    BMC Cardiovasc Disord; 2018 Aug; 18(1):163. PubMed ID: 30092774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.